SunBio,Inc. (KOSDAQ: 067370)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,060.00
+40.00 (0.57%)
Jan 21, 2025, 3:00 PM KST
-29.40%
Market Cap 87.80B
Revenue (ttm) 2.17B
Net Income (ttm) 1.39B
Shares Out 12.31M
EPS (ttm) 249.33
PE Ratio 28.60
Forward PE n/a
Dividend 75.00 (1.06%)
Ex-Dividend Date Dec 27, 2024
Volume 1,450
Average Volume 6,106
Open 7,030.00
Previous Close 7,020.00
Day's Range 7,000.00 - 7,080.00
52-Week Range 5,580.00 - 10,280.00
Beta 0.86
RSI 48.24
Earnings Date Sep 13, 2024

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 067370
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.